Unbiased genetic screening for a variety of cancers has shown that BRD4 is critical for cell survival and a promising anticancer target [21], such as acute myeloid leukemia [22], glioblastoma [23] and lung adenocarcinoma [24]. The gene discussed is BRD4; the disease is acute myeloid leukemia.